Combined Language and Arm Therapy for Chronic Stroke Survivors
Tests a combined language and robot-assisted arm program in adults with chronic stroke.
Plain-language title generated from the registry record
Registry title: Combined Aphasia and Robot-Assisted Arm Treatment for Chronic Stroke Survivors
Key facts
- Where
- Valhalla, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 90 years old?
Source: NCT07000019, who can take part
Where in United States
- Westchester Medical Center / New York Medical CollegeValhalla, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- New York Medical College
- Trial code
- NCT07000019
- Record updated
- 31 May 2025
- Original description
The goal of this clinical trial is to learn if a program that combines language and arm treatment can improve language and movement problems in people with chronic stroke. The mains questions it aims to answer are:Read full original descriptionShow less
Combined Aphasia and Robot-Assisted Arm Treatment for Chronic Stroke Survivors
The goal of this clinical trial is to learn if a program that combines language and arm treatment can improve language and movement problems in people with chronic stroke. The mains questions it aims to answer are:
* To determine the extent to which this combined treatment can improve language. * To determine the extent to which the combined treatment can improve arm movements.
Researchers will compare the effects of this combined treatment with treatment that targets arm movements alone.
Inclusion: Male or female patients between 18-90 years of age; Right-handed prior to stroke; English-speaking (monolingual); History of single left-hemisphere stroke at least 6 months prior to enrollment; Presence of aphasia and naming deficits on Western Aphasia Battery (WAB-R); Comprehension score above 4 on WAB-R; Unilateral upper limb paresis (Fugl-Meyer Upper Extremity score <56); Documentation of signed Informed Consent by the study participant.
Exclusion: Diagnosis or history of speech impairment prior to stroke; Inability to perform screening tasks due to severe language and/or cognitive impairment; Condition limiting passive movement in the range of motion required for robotic therapy (e.g. fixed contracture); Any medical or psychiatric condition that may impact participation or compliance with study procedures or activities in the opinion of the investigator; Severely limited speech output (score below 2 on spontaneous speech portion of WAB-R).